Pre-hypertrophic chondrogenic enhancer landscape of limb and axial skeleton development.
Fabrice DarbellayAnna RamischLucille Lopez-DelisleMichael KosickiAntonella RauseoZahra JouiniAxel ViselGuillaume AndreyPublished in: Nature communications (2024)
Chondrocyte differentiation controls skeleton development and stature. Here we provide a comprehensive map of chondrocyte-specific enhancers and show that they provide a mechanistic framework through which non-coding genetic variants can influence skeletal development and human stature. Working with fetal chondrocytes isolated from mice bearing a Col2a1 fluorescent regulatory sensor, we identify 780 genes and 2'704 putative enhancers specifically active in chondrocytes using a combination of RNA-seq, ATAC-seq and H3K27ac ChIP-seq. Most of these enhancers (74%) show pan-chondrogenic activity, with smaller populations being restricted to limb (18%) or trunk (8%) chondrocytes only. Notably, genetic variations overlapping these enhancers better explain height differences than those overlapping non-chondrogenic enhancers. Finally, targeted deletions of identified enhancers at the Fgfr3, Col2a1, Hhip and, Nkx3-2 loci confirm their role in regulating cognate genes. This enhancer map provides a framework for understanding how genes and non-coding variations influence bone development and diseases.
Keyphrases
- genome wide
- rna seq
- single cell
- mesenchymal stem cells
- transcription factor
- dna methylation
- endothelial cells
- type diabetes
- metabolic syndrome
- quantum dots
- binding protein
- gene expression
- body composition
- adipose tissue
- cancer therapy
- high throughput
- physical activity
- skeletal muscle
- bioinformatics analysis
- oxidative stress
- genome wide identification
- single molecule
- induced pluripotent stem cells
- growth hormone